首页> 外国专利> METHODS OF TREATING B2-BRADYKININ RECEPTOR MEDIATED ANGIOEDEMA

METHODS OF TREATING B2-BRADYKININ RECEPTOR MEDIATED ANGIOEDEMA

机译:治疗B2-缓激肽受体介导的血管性血管病的方法

摘要

Methods of treating B2-bradykinin receptor mediated angioedema in a subject by administering a composition containing a 8-(heteroarylmethoxy)quinolone compound, a 8-(arylmethoxy)quinoline compound, or a salt, a stereoisomer, a hydrate, or a solvate thereof. Oral formulations containing a 8-(heteroarylmethoxy)quinolone compound, a 8-(arylmethoxy)quinoline compound, or a salt, a stereoisomer, a hydrate, or a solvate thereof for the treatment of B2-bradykinin receptor mediated angioedema. Use of a composition containing a 8-(heteroarylmethoxy)quinolone compound, a 8-(arylmethoxy)quinoline compound, or a salt, a stereoisomer, a hydrate, or a solvate thereof for the manufacture of a medicament for the treatment and/or prevention of a B2-bradykinin receptor mediated angioedema.
机译:通过施用包含8-(杂芳基甲氧基)喹诺酮化合物,8-(芳基甲氧基)喹啉化合物或盐,立体异构体的组合物来治疗受试者中B 2 -缓激肽受体介导的血管性水肿的方法,水合物或其溶剂化物。含有8-(杂芳基甲氧基)喹诺酮化合物,8-(芳基甲氧基)喹啉化合物或其盐,立体异构体,水合物或溶剂化物的口服制剂,用于治疗B 2 -缓激肽受体介导的血管性水肿。包含8-(杂芳基甲氧基)喹诺酮化合物,8-(芳基甲氧基)喹啉化合物或其盐,立体异构体,水合物或溶剂化物的组合物在制备用于治疗和/或预防的药物中的用途B 2 -缓激肽受体介导的血管性水肿

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号